scorecard
  1. Home
  2. Science
  3. Health
  4. news
  5. Haven, the Amazon-Berkshire Hathaway-JPMorgan health venture, is disbanding

Haven, the Amazon-Berkshire Hathaway-JPMorgan health venture, is disbanding

Lydia Ramsey Pflanzer   

Haven, the Amazon-Berkshire Hathaway-JPMorgan health venture, is disbanding
Science2 min read

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.

Hello,

Well, we're only one workday into 2021 and we've already seen a Slack outage, a national coronavirus lockdown in the UK, and the demise of Haven, the Amazon-Berkshire Hathaway-JPMorgan healthcare venture. I guess I shouldn't have expected anything less following 2020's news cycle.

Before we jump into today's news, I wanted to give a big welcome to Patricia Kelly Yeo, who joins us this week as a healthcare fellow! She'll help us follow the news of this massive industry, from vaccine coverage to startups. You can reach out to say hi via email at pyeo@businessinsider.com and on Twitter at @patkyeo.

Today in healthcare news: Why Haven was doomed from the start, how primary care chains are preparing for vaccinations, and the UK's plan to give "tens of millions" of AstraZeneca-Oxford doses by the end of March.

3 reasons why Haven, Amazon's joint healthcare venture with JPMorgan and Berkshire Hathaway, was doomed from the start

Read the full analysis from Blake Dodge here>>

Primary-care clinics hope to play a big role in vaccinating Americans, but some don't know when they'll receive coronavirus shots. 3 major chains lay out how they're preparing despite little information.

Read the full story from Shelby Livingston here>>

UK government says it will give 'tens of millions' AstraZeneca-Oxford COVID-19 vaccine doses by end of March - here's how.

Read the full story from Dr. Catherine Schuster-Bruce here>>

More stories we're reading:

- Lydia

READ MORE ARTICLES ON


Advertisement

Advertisement